One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about ...

Xofluza (baloxavir marboxil) met its primary endpoint in the CENTERSTONE trial, reducing the odds of untreated household ...

One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about ...

A single dose of the antiviral baloxavir marboxil (Xofluza) led to a lower incidence of influenza virus transmission to ...

Baloxavir marboxil (baloxavir) rapidly reduces influenza virus shedding, which suggests that it may reduce transmission. Studies of treatment with neuraminidase inhibitors have not shown ...

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...

A landmark study published in The New England Journal of Medicine [link to the publication] reveals that a single oral dose of baloxavir marboxil ...

Baloxavir marboxil (baloxavir) is an oral antiviral medication that is FDA-approved for early treatment (within 48 hours after symptom onset) of uncomplicated influenza and for postexposure ...

2025年4月25日，罗氏全球宣布，速福达®（玛巴洛沙韦）III期临床试验CENTERSTONE研究详细结果在《新英格兰医学杂志》（NEJM）上发布。[1]结果显示研究达到了主要终点：流感感染者单次口服速福达®（玛巴洛沙韦）后，其未接受治疗的家庭成员 ...

The Canadian Cancer Society (CCS) closed the 32nd edition of its prestigious Montreal Daffodil Ball by raising a historic amount of $3,413,908. Presented under the theme Prospective, the Ball ...

March 2025. "We had a solid start to the year with sales growth across all business areas and delivered Saab's strongest first quarter to date. Fully committed to contributing to the European defence ...